1. More then 10 years as Editor-in-Chief of Neurological Sciences: greetings and acknowledgements

   • Antonio Federico

   Editorial 27 November 2021 Pages: 4861 - 4863

   

2. Cognitive impairment in young COVID-19 patients: the tip of the iceberg?

   • Claudio Solaro
   • Giulia Gamberini
   • Fabio Giuseppe Masuccio

   COVID-19 17 August 2021 Pages: 4865 - 4866

3. Neurological manifestations of COVID-19 in patients: from path physiology to therapy

   • J. J. Merino
   • A. Macho-González
   • M. P. González

   COVID-19 21 August 2021 Pages: 4867 - 4879

   

4. SARS-CoV-2 infection after alemtuzumab in a multiple sclerosis patient: milder disease symptoms in comparison with coinfected relatives: a case report and review of the literature

   • Lorenzo Saraceno
   • Emanuela Laura Susani
   • Alessandra Protti

   COVID-19 24 August 2021 Pages: 4881 - 4884

5. Focal neurological deficits from multiple thromboembolic stroke complicating COVID-19 and limitations of stroke management during outbreak in Korea

   • Soo-Hyun Park
   • Woo Chang Chun

   COVID-19 Open access 25 August 2021 Pages: 4885 - 4887

   

6. Myasthenia gravis and telemedicine: a lesson from COVID-19 pandemic

   • Dario Ricciardi
   • Silvia Casagrande
   • on behalf of the Digital Technologies, Web, Social Media Study Group of the Italian Society of Neurology

   COVID-19 26 August 2021 Pages: 4889 - 4892

7. Critical illness neuropathy in severe COVID-19: a case series

   • Tommaso Bocci
   • Laura Campiglio
   • Alberto Priori

   COVID-19 03 September 2021 Pages: 4893 - 4898

   

8. Early reversible leukoencephalopathy and unilateral sixth cranial nerve palsy in mild COVID-19 infection

   • Federico Piazza
   • Marco Bozzali
   • Leonardo Lopiano

   COVID-19 04 September 2021 Pages: 4899 - 4902

   

9. Long-term neurological manifestations of COVID-19: prevalence and predictive factors

   • Andrea Pilotto
   • Viviana Cristillo
   • Alessandro Padovani

   COVID-19 Open access 15 September 2021 Pages: 4903 - 4907

   

10. Spontaneous thrombosis of cerebral arteriovenous malformation post COVID-19

    • Sofia Grenho Rodrigues
    • Renato Oliveira
    • Sofia Nunes Oliveira

    COVID-19 15 September 2021 Pages: 4909 - 4911

    

11. Alzheimer’s disease in elderly COVID-19 patients: potential mechanisms and preventive measures

    • Haili Wang
    • Juan Lu
    • Yingzhu Chen

    COVID-19 22 September 2021 Pages: 4913 - 4920

    

12. Qualitative smell/taste disorders as sequelae of acute COVID-19

    • Tommaso Ercoli
    • Carla Masala
    • Giovanni Defazio

    COVID-19 Open access 23 September 2021 Pages: 4921 - 4926

    

13. “Parkinson’s disease” on the way to progressive supranuclear palsy: a review on PSP-parkinsonism

    • Ján Necpál
    • Miroslav Borsek
    • Bibiána Jeleňová

    Review Article 17 September 2021 Pages: 4927 - 4936

14. Influence of the gut microbiome on inflammatory and immune response after stroke

    • Qin Huang
    • Jian Xia

    Review Article 18 September 2021 Pages: 4937 - 4951

    

15. Driving and Alzheimer’s dementia or mild cognitive impairment: a systematic review of the existing guidelines emphasizing on the neurologist’s role

    • Petros Stamatelos
    • Alexandra Economou
    • Sokratis G. Papageorgiou

    Review Article 28 September 2021 Pages: 4953 - 4963

    

16. The management of Chiari malformation type 1 and syringomyelia in children: a review of the literature

    • Veronica Saletti
    • Mariangela Farinotti
    • Laura Grazia Valentini

    Review Article 30 September 2021 Pages: 4965 - 4995

    

17. Compensating for verbal-motor deficits in neuropsychological assessment in movement disorders: sensitivity and specificity of the ECAS in Parkinson’s and Huntington’s diseases

    • Laura Carelli
    • Federica Solca
    • Barbara Poletti

    Original Article 16 March 2021 Pages: 4997 - 5006

    

18. Multidimensional predicting model of intracranial aneurysm stability with backpropagation neural network: a preliminary study

    • Yi Yang
    • Qingyuan Liu
    • Shuo Wang

    Original Article 16 March 2021 Pages: 5007 - 5019

    

19. Neuropsychiatric symptoms among young stroke survivors—frequency, patterns, and associated factors

    • Done Indira Priya
    • Rajeswari Aghoram
    • Sunil K. Narayan

    Original Article 17 March 2021 Pages: 5021 - 5027

    

20. Comparative study between idiopathic and non-idiopathic dystonia: a prospective observational study

    • Rupesh Prasad
    • Anand Kumar
    • Deepika Joshi

    Original Article 18 March 2021 Pages: 5029 - 5035

21. Nabiximols and botulinum toxin injections for patients with multiple sclerosis: efficacy on spasticity and spasms in a single-centre experience

    • Arianna Sartori
    • Alessandro Dinoto
    • Paolo Manganotti

    Original Article 19 March 2021 Pages: 5037 - 5043

22. Effectiveness of a dance-physiotherapy combined intervention in Parkinson’s disease: a randomized controlled pilot trial

    • Elisa Frisaldi
    • Piero Bottino
    • Fabrizio Benedetti

    Original Article 20 March 2021 Pages: 5045 - 5053

    

23. Clinical characteristics of patients with ischemic stroke after the 2016 Kumamoto earthquake, a multi-center study

    • Yuichiro Inatomi
    • Makoto Nakajima
    • Yanosuke Kouzaki

    Original Article 20 March 2021 Pages: 5055 - 5063

    

24. Low blood caspase-8 levels in survivor patients of traumatic brain injury

    • Leonardo Lorente
    • María M. Martín
    • Alejandro Jiménez

    Original Article 23 March 2021 Pages: 5065 - 5070

    

25. Vertigo without cochlear symptoms: vestibular migraine or Menière disease?

    • Roberto Teggi
    • Marco Familiari
    • Mario Bussi

    Original Article 25 March 2021 Pages: 5071 - 5076

26. A novel homozygous splice-site mutation in SCARB2 is associated with progressive myoclonic epilepsy with renal failure

    • Abolfazl Yari
    • Reza Molla Ali-Nejad
    • Nasrollah Saleh-Gohari

    Original Article 26 March 2021 Pages: 5077 - 5085

    

27. Effects of the onabotulinumtoxinA follow-up delay in migraine course during the COVID-19 lockdown

    • Alicia Gonzalez-Martinez
    • Álvaro Planchuelo-Gómez
    • Ana Beatriz Gago-Veiga

    Original Article 26 March 2021 Pages: 5087 - 5092

    

28. Serum transthyretin and risk of cognitive decline and dementia: 22-year longitudinal study

    • Marzieh Araghi
    • Martin J. Shipley
    • Eric J. Brunner

    Original Article 26 March 2021 Pages: 5093 - 5100

    

29. Efficacy of aspirin for sporadic vestibular schwannoma: a meta-analysis

    • Katrina Hannah D. Ignacio
    • Adrian I. Espiritu
    • Abdelsimar T. Omar II

    Original Article 26 March 2021 Pages: 5101 - 5106

    

30. The relationship between attention and static balance disturbance in patients with Parkinson’s disease

    • Amir Dana
    • Amir Shams
    • Alireza Bahrami

    Original Article 27 March 2021 Pages: 5107 - 5115

    

31. Cerebrovascular and cardiovascular disease burden in patients with hereditary hemorrhagic telangiectasia

    • Mudassir Farooqui
    • Sajid Suriya
    • Atif Zafar

    Original Article 29 March 2021 Pages: 5117 - 5122

    

32. Leber hereditary optic neuropathy and dystonia overlapping mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes due to m.14459G>A mutation

    • Xiaolin Yu
    • Kunqian Ji
    • Chuanzhu Yan

    Original Article 29 March 2021 Pages: 5123 - 5130

    

33. The role of CE-MRA of the supraortic vessels in the detection of associated intracranial pathology

    • Sonia Francesca Calloni
    • Marianna Perrotta
    • Nicoletta Anzalone

    Original Article 29 March 2021 Pages: 5131 - 5137

    

34. Abnormal neurological pupil index is associated with malignant cerebral edema after mechanical thrombectomy in large vessel occlusion patients

    • Ehsan Dowlati
    • Kwadwo Sarpong
    • Daniel R. Felbaum

    Original Article 29 March 2021 Pages: 5139 - 5148

    

35. Rivermead assessment of somatosensory performance: Italian normative data

    • Cristina Russo
    • Viviana Spandri
    • Giuseppe Vallar

    Original Article Open access 30 March 2021 Pages: 5149 - 5156

    

36. Cancer risk for multiple sclerosis patients treated with azathioprine and disease-modifying therapies: an Italian observational study

    • Loredana La Mantia
    • Maria Donata Benedetti
    • Marco Rovaris

    Original Article 31 March 2021 Pages: 5157 - 5163

37. Evaluating the optic nerve stiffness and optic nerve sheath diameter in idiopathic intracranial hypertension patients after the resolution of papilledema

    • Fatma Selin Kaya
    • Ersoy Bayram
    • Ercan İnci

    Original Article 31 March 2021 Pages: 5165 - 5170

    

38. The value of asphericity derived from T1-weighted MR in differentiating intraparenchymal ring-enhancing lesions–comparison of glioblastomas and brain abscesses

    • Tao Zeng
    • Zijun Xu
    • Jianhua Yan

    Original Article 01 April 2021 Pages: 5171 - 5175

    

39. Geographic differences in the incidence of Huntington’s disease in Sardinia, Italy

    • Antonella Muroni
    • Maria R. Murru
    • Giovanni Defazio

    Original Article 01 April 2021 Pages: 5177 - 5181

    

40. Cognitive impairment in multiple sclerosis: diagnosis and monitoring

    • Virginia Meca-Lallana
    • Francisco Gascón-Giménez
    • Francisco Pérez-Miralles

    Original Article Open access 01 April 2021 Pages: 5183 - 5193

    

41. Two novel missense variants in SPTBN2 likely associated with spinocerebellar ataxia type 5

    • Xianli Bian
    • Shang Wang
    • Ping Wang

    Original Article Open access 02 April 2021 Pages: 5195 - 5203

    

42. High-resolution ultrasound changes of the vagus nerve in idiopathic Parkinson’s disease (IPD): a possible additional index of disease

    • F. Sartucci
    • T. Bocci
    • G. Orlandi

    Original Article Open access 05 April 2021 Pages: 5205 - 5211

    

43. Characteristics of pupil palsy in miller-fisher syndrome: case reports and review of the literature

    • Jang Ho Lee
    • Yeonji Jang
    • Jae Ho Jung

    Original Article 06 April 2021 Pages: 5213 - 5218

    

44. Robotic rehabilitation for end-effector device and botulinum toxin in upper limb rehabilitation in chronic post-stroke patients: an integrated rehabilitative approach

    • Teresa Paolucci
    • Francesco Agostini
    • Raoul Saggini

    Original Article Open access 07 April 2021 Pages: 5219 - 5229

    

45. Mosaic ring chromosome 18 in a Chinese child with epilepsy: a case report and review of the literature

    • Jing Wang
    • Ling Xiao
    • Xiaoyan Long

    Original Article 08 April 2021 Pages: 5231 - 5239

    

46. Disability progression in multiple sclerosis is associated with plasma neuroactive steroid profile

    • C. Cheng
    • D. Gomez
    • C. Power

    Original Article 08 April 2021 Pages: 5241 - 5247

    

47. Effects of virtual reality in post-stroke aphasia: a systematic review and meta-analysis

    • Yun Cao
    • Xing Huang
    • Jingling Chang

    Original Article 09 April 2021 Pages: 5249 - 5259

    

48. The effect of ketogenic diet on thyroid functions in children with drug-resistant epilepsy

    • Ünsal Yılmaz
    • Özlem Nalbantoğlu
    • Behzat Özkan

    Original Article 12 April 2021 Pages: 5261 - 5269

    

49. What might cervical vestibular–evoked myogenic potential abnormalities mean in essential tremor?

    • Feray Gulec Uyaroglu
    • Roza Ucar
    • Nese Celebisoy

    Original Article 15 April 2021 Pages: 5271 - 5276

50. Narrative Medicine to integrate patients’, caregivers’ and clinicians’ migraine experiences: the DRONE multicentre project

    • Maria Clara Tonini
    • Alessandra Fiorencis
    • Maria Giulia Marini

    Original Article Open access 15 April 2021 Pages: 5277 - 5288